Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the recipient of a significant decline in short interest in February. As of February 28th, there was short interest totalling 12,400 shares, a decline of 17.3% from the February 13th total of 15,000 shares. Approximately 0.9% of the shares of the company are short sold. Based on an average daily trading volume, of 1,150,000 shares, the short-interest ratio is presently 0.0 days.
Arcadia Biosciences Stock Performance
NASDAQ:RKDA traded up $0.16 on Wednesday, hitting $3.46. 684 shares of the stock were exchanged, compared to its average volume of 313,036. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $10.31. The stock has a market capitalization of $4.72 million, a price-to-earnings ratio of -0.81 and a beta of 0.86. The company’s 50-day moving average price is $4.42 and its 200 day moving average price is $4.11.
Wall Street Analysts Forecast Growth
Separately, StockNews.com initiated coverage on Arcadia Biosciences in a research note on Saturday. They issued a “sell” rating on the stock.
Institutional Investors Weigh In On Arcadia Biosciences
An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC purchased a new position in Arcadia Biosciences, Inc. (NASDAQ:RKDA – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned about 0.90% of Arcadia Biosciences as of its most recent SEC filing. 17.73% of the stock is currently owned by institutional investors.
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Read More
- Five stocks we like better than Arcadia Biosciences
- How to Effectively Use the MarketBeat Ratings Screener
- D-Wave and Quantum Supremacy: Implications For Investors
- 3 Tickers Leading a Meme Stock Revival
- 3 Cash Cow Stocks Leading Their Sectors in Free Cash Flow Margins
- How to Invest in the Best Canadian StocksĀ
- Retail Sales Data Signals a Surge: The E-Commerce Stock Picks
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.